Osteoporosis screening using FRAX by community pharmacists and Collaborative pharmacotherapy in the osteoporotic treatment

Osteoporosis screening using FRAX by community pharmacists and Collaborative pharmacotherapy in the osteoporotic treatment - Osteoporosis screening using FRAX by community pharmacists and Collaborative pharmacotherapy in the osteoporotic treatment

Status

Recruiting

Phases

Unknown

Study type

Interventional

Source

JPRN

Registry ID

JPRN-UMIN000018306

Enrollment

100

Registered

2015-07-14

Start date

2015-05-01

Completion date

Unknown

Last updated

2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Osteoporosis

Interventions

pharmacist interventions in osteoporosis management by screening using FRAX usual pharmaceutical care

Eligibility

Sex/Gender

Female

Inclusion criteria

Inclusion criteria: 1 women over 50 years of age 2.patients whose content is obtained in written form

Exclusion criteria

Exclusion criteria: women currently on prescription osteoporosis medications

Design outcomes

Primary

Measure	Time frame
1. rate of osteoporosis screening follow-up exams 2. osteoporosis treatment adherence	—

Secondary

Measure	Time frame
1.risk of fracture 2.rate of pharmacotherapy	—

Countries

Japan

Contacts

Public ContactKunizo Arai

Institute of Medical, Pharmaceutical, and Health Sciences. Kanazawa University Faculty of Pharmacy

arai@p.kanazawa-u.ac.jp+81762646224

Outcome results

None listed

Source: JPRN (via WHO ICTRP) · Data processed: Jul 3, 2026